Peripheral Blood versus Bone Marrow as a Source of Hematopoietic Stem Cells for Allogeneic Transplantation in Children With Class I and II Beta Thalassemia Major-Reference-Cited by-同舟云学术

Peripheral Blood versus Bone Marrow as a Source of Hematopoietic Stem Cells for Allogeneic Transplantation in Children With Class I and II Beta Thalassemia Major

Published:2008-03 Issue:3 Volume:14 Page:301-308
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Ghavamzadeh Ardeshir,Iravani Masood,Ashouri Aseaeh,Mousavi Seyed Asadollah,Mahdavi Nastaran,Shamshiri Ahmadreza,Hadjibabaie Molouk,Namdar Rocsanna,Nedaeifard Leila,Ghaffari Hamidollah,Alimoghaddam Kamran

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference29 articles.

1. The beta-thalassemias;Olivieri;N Engl J Med,1999

2. The Thalassaemia Syndromes;Weatherall,2002

3. The cure of thalassemia by bone marrow transplantation;Lucarelli;Blood Rev,2002

4. Marrow transplantation in patients with advanced thalassemia;Lucarelli;N Engl J Med,1987

5. Bone marrow transplantation in patients with thalassemia;Lucarelli;N Engl J Med,1990

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Initiation of Haploidentical Stem Cell Transplantation With Post‐Transplant Cyclophosphamide in Children: A Low–Middle‐Income Country Institutional Experience;Pediatric Transplantation;2024-08-19

2. The Thalassemia Syndromes: New Insights;Thalassemia Syndromes - New Insights and Transfusion Modalities;2023-11-22

3. Hematopoietic Stem Cell Transplantation in Thalassemia;Hematology/Oncology Clinics of North America;2023-04

4. Conditioning Regimens in Patients with β-Thalassemia Who Underwent Hematopoietic Stem Cell Transplantation: A Scoping Review;Journal of Clinical Medicine;2022-02-09

5. Curative therapy for hemoglobinopathies: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo stem cell gene therapy versus allogeneic hematopoietic stem cell transplantation;Cytotherapy;2021-12